SEARCH

SEARCH BY CITATION

References

  • Alving, B.M., Barr, C.F., Johansen, L.E. & Tang, D.B. (1992) Comparison between a one-point dilute phospholipid APTT and the dilute Russell Viper Venom Time for verification of lupus anticoagulants. Thrombosis and Haemostasis, 67, 672–678.
  • Arnout, J., Huybrechts, E., Vanrusselt, M. & Vermylen, J. (1992) A new lupus anticoagulant neutralization test based on platelet derived vesicles. British Journal of Haematology, 80, 341–346.
  • Arnout, J., Vanrusselt, E., Huybrechts, E. & Vermylen, J. (1994) Optimization of the dilute prothrombin time for the detection of the lupus anticoagulant by use of a recombinant tissue thromboplastin. British Journal of Haematology, 87, 94–99.
  • Backos, M., Rai, R., Baxter, N., Chilcott, I.T., Cohen, H. & Regan, L. (1999) Pregnancy complications in women with recurrent miscarriage associated with antiphospholipid antibodies treated with low dose aspirin and heparin. British Journal of Obstetrics and Gynaecology, 106, 102–107.
  • Brancaccio, V., Ames, P.R.J., Glynn, J., Iannaccone, L. & Mackie, I.J. (1997) A rapid screen for lupus anticoagulant with good discrimination from oral anticoagulants, congenital factor deficiency and heparin, is provided by comparing a sensitive and an insensitive APTT reagent. Blood Coagulation and Fibrinolysis, 8, 155–160.
  • Branch, D.W., Silver, R.M., Blackwell, J.L., Reading, J.C. & Scott, J.R. (1992) Outcome of treated pregnancies in women with antiphospholipid syndrome: an update of the Utah experience. Obstetrics and Gynecology, 80, 614–620.
  • Brandt, J.T., Triplett, D.A., Rock, W.A., Bovill, E.G. & Arkin, C.F. (1991) Effect of lupus anticoagulants on the activated partial thromboplastin time. Archives of Pathological Laboratory Medicine, 115, 109–114.
  • Brandt, J.T., Triplett, D.A., Alving, B. & Scharrer, I. (1995) Criteria for the diagnosis of lupus anticoagulants: an update. Thrombosis and Haemostasis, 74, 1185–1190.
  • Cabides, J., Cabral, A. & Alarcon-Segovia, D. (1995) Clinical manifestations of antiphospholipid syndrome in patients with systemic lupus erythematosus associate more strongly with anti beta2 glycoprotein I than with antiphospholipid antibodies. Journal of Rheumatology, 22, 1899–1906.
  • Carreras, L.O., Perez, G.N., Vega, H.R. & Casavilla, F. (1988) Lupus anticoagulant and recurrent fetal loss: successful treatment with gammaglobulin. Lancet, ii, 393–394.
  • Chantarangkul, V., Tripodi, A., Arbini, A. & Mannucci, P.M. (1992) Silica clotting time (SCT) as a screening and confirmatory test for detection of the lupus anticoagulant. Thrombosis Research, 67, 355–365.
  • Cowchock, F.S., Reece, E.A., Balaban, D., Branch, D.W. & Plouffe, L. (1992) Repeated fetal losses associated with antiphospholipid antibodies: a collaborative randomised trial comparing prednisone with low-dose aspirin treatment. American Journal of Obstetrics and Gynecology, 166, 1318–1323.
  • Creagh, M.D., Duncan, S.L.B., McDonnell, J.M. & Greaves, M. (1991) Failure of the detection of antiphospholipid antibodies alone to predict poor pregnancy outcome (Abstract). British Journal of Haematology, 77 (Suppl. 1), 4.
  • Della Valle, P., Crippa, L., Safa, O., Tomassini, L., Pattarini, E., Vigano-Díangelo, S., Grazia Sabbadini, M. & Díangelo, A. (1996) Potential failure of the International Normalised Ratio (INR) System in the monitoring of oral anticoagulation in patients with lupus anticoagulants. Annales de Medecine Interne, 147, 10–14.
  • Exner, T., Rickard, A. & Kronberg, H. (1979) A sensitive test for demonstration lupus anticoagulant and its behavioural patterns. British Journal of Haematology, 40, 143–151.
  • Finazzi, G., Brancaccio, V., Moia, M., Ciaverella, N., Mazzucconi, M.G., Schinco, P.C., Ruggeri, M., Pogliani, E.M., Gamba, G., Rossi, E., Baudo, F., Manotti, C., D’Angelo, A., Palareti, G., De Stefano, V., Berrettini, M. & Barbui, T. (1996) Natural history and risk factors for thrombosis in 360 patients with antiphospholipid antibodies: a four year prospective study from the Italian Registry. American Journal of Medicine, 100, 530–536.
  • Forastiero, R.R., Cerrato, G.S. & Carreras, L.O. (1994) Evaluation of recently described tests for detection of the lupus anticoagulant. Thrombosis and Haemostasis, 72, 728–733.
  • Galli, M., Comfurius, P., Maassen, C., Hemker, H.C., De Baets, M.H., Van Breda-Vriesman, P.J., Barbui, T., Zwaal, R.F. & Bevers, E.M. (1990) Anticardiolipin antibodies directed not to cardiolipin but to a plasma protein cofactor. Lancet, 335, 1544–1547.
  • Ginsburg, K.S., Liang, M.H., Newcomer, L., Goldhaber, S.Z., Schur, P.H., Hennekens, C.H. & Stampfer, M.J. (1992) Anticardiolipin antibodies and the risk for ischemic stroke and venous thrombosis. Annals of Internal Medicine, 117, 997–1002.
  • Godeau, B., Piette, J.C., Fromont, P., Intrator, L., Schaeffer, A. & Bierling, P. (1997) Specific antiplatelet glycoprotein autoantibodies are associated with the thrombocytopenia of primary antiphospholipid syndrome. British Journal of Haematology, 98, 873–879.
  • Greaves, M. (1999) Antiphospholipid antibodies and thrombosis. Lancet, 353, 1348–1353.
  • Guerin, J., Feighery, C., Sim, R.B. & Jackson, J. (1997) Antibodies to beta 2-glycoprotein I: a specific marker for the antiphospholipid syndrome. Clinical Experimental Immunology, 109, 304–309.
  • Harris, E.N., Gharavi, A.E., Patel, S.P. & Hughes, G.R.V. (1987) Evaluation of the anticardiolipin antibody test: report of a standardisation workshop, held April 4th 1986. Clinical Experimental Immunology, 68, 215–222.
  • Jennings, I., Woods, T.A.L., Kitchen, S., Preston, F.E. & Greaves, M. (1997) Potentially clinically important inaccuracies in testing for the lupus anticoagulant: an analysis of the results from the surveys of the UK national external quality assurance scheme (NEQAS) in blood coagulation. Thrombosis and Haemostasis, 77, 810–811.
  • Kearon, G., Gent, M., Hirsh, J., Weitz, J., Kovacs, M.J., Anderson, D.R., Turpie, A.G., Green, D., Ginsberg, J.S., Wells, P., Mackinnon, B. & Julian, J.A. (1999) A comparison of three months of anticoagulation with extended anticoagulation for a first episode of idiopathic venous thromboembolism. New England Journal of Medicine, 340, 901–907.
  • Kelsey, P.R., Stevenson, K.J. & Poller, L. (1984) The diagnosis of lupus anticoagulant by the activated partial thromboplastin time. The central role of phosphatidyl serine. Thrombosis and Haemostasis, 52, 172–175.
  • Khamashta, M.A. & Hughes, G.R.V. (1993) ACP Broadsheet no. 136. Detection and importance of anticardiolipin antibodies. Journal of Clinical Pathology, 46, 104–107.
  • Khamashta, M.A., Cuadrado, M.J., Mujic, F., Taub, N.A., Hunt, B.J. & Hughes, G.R.V. (1995) The management of thrombosis in the antiphospholipid-antibody syndrome. New England Journal of Medicine, 332, 993–997.
  • Kutteh, W.H. (1996) Antiphospholipid antibody-associated recurrent pregnancy loss: treatment with heparin and low-dose aspirin is superior to low-dose aspirin alone. American Journal of Obstetrics and Gynecology, 174, 1584–1589.
  • Kwak, J.Y.H., Barini, R., Gilman-Sachs, A., Beaman, K.D. & Beer, A.E. (1994) Down-regulation of maternal antiphospholipid antibodies during early pregnancy and pregnancy outcome. American Journal of Obstetrics and Gynecology, 171, 239–246.
  • Laskin, C.A., Bombardier, C., Hannah, M.E., Mandel, F.P., Knox Ritchie, J.W., Farewell, V., Farine, D., Spitzer, K., Fielding, L., Soloninka, C.A. & Yeung, Y. (1997) Prednisone and aspirin in women with autoantibodies and unexplained recurrent fetal loss. New England Journal of Medicine, 337, 148–153.
  • Lawrie, A.S., Mackie, I.J., Purdy, G. & Machin, S.J. (1999) The sensitivity and specificity of commercial reagents for the detection of lupus anticoagulant show marked differences in performance between photo-optical and mechanical coagulometers. Thrombosis and Haemostasis, 81: 758762.
  • Leuzzi, R.A., Davis, G.H., Cowchock, F.S., Murphy, S. & Vernick, J.J. (1997) Management of immune thrombocytopenic purpura associated with antiphospholipid antibody syndrome. Clinical and Experimental Rheumatology, 15, 197–200.
  • Loizou, S., McCrea, J.D., Rudge, A.C., Reynolds, R., Boyle, C.C. & Harris, E.N. (1985) Measurement of anticardiolipin antibodies by enzyme-linked immunosorbent assay (ELISA): standardisation and quantitation of results. Clinical Experimental Immunology, 62, 783–745.
  • Machin, S.J., Giddings, J.C., Greaves, M., Hutton, R.A., Mackie, I.J., Malia, R.G. & Taberner, D.A. (1991) Guidelines on testing for the lupus anticoagulant. Journal of Clinical Pathology, 1991, 885–889.
  • Matsuura, E., Igarashi, Y., Fujimoto, M., Ichikawa, K. & Koike, T. (1990) Anticardiolipin cofactor(s) and differential diagnosis of autoimmune disease. Lancet, 336, 177–178.
  • McNally, T., Mackie, I.J., Machin, S.J. & Isenburg, D.A. (1995) Increased levels of beta 2 glycoprotein-I antigen and beta 2 glycoprotein-I binding antibodies are associated with a history of thromboembolic complications in patients with SLE and primary antiphospholipid syndrome. British Journal of Rheumatology, 34, 1031–1036.
  • McNeil, H.P., Simpson, R.J., Chesterman, C.N. & Krilis, S.A. (1990) Antiphospholipid antibodies are directed against a complex antigen that includes a lipid binding inhibitor of coagulation: beta 2-glycoprotein 1 (apolipoprotein H). Proceedings of the National Academy of Sciences of the United States of America, 87, 4120–4124.
  • Meade, T.W. & Miller, G.J. (1995) Combined use of aspirin and warfarin in primary prevention of ischemic heart disease in men at high risk. American Journal of Cardiology, 75, 23B–26B.
  • Medical Devices Agency (MDA) (1998) Evaluation of Lupus Anticoagulant Kits. MDA\98\48, Department of Health.
  • Moll, S. & Ortel, T.L. (1997) Monitoring warfarin therapy in patients with lupus anticoagulants. Annals of Internal Medicine, 127, 177–185.
  • Palareti, G., Leali, N., Coccheri, S., Poggi, M., Manotti, C., Díangelo, A., Pengo, V., Erba, N., Moia, M., Ciavarella, N., Devoto, G., Berrettini, M. & Musolesi, S. (1996) Bleeding complications of oral anticoagulant treatment: an inception-cohort, prospective collaboration study (ISCOAT). Lancet, 348, 423–428.
  • Prandoni, P., Lensing, A.W.A., Cogo, A., Cuppini, S., Villalta, S., Carta, M., Cattelan, A.M., Polistena, P., Bernardi, E. & Prins, M.H. (1996) The long-term clinical course of acute deep venous thrombosis. Annals of Internal Medicine, 125, 1–7.
  • Prandoni, P., Lensing, A.W.A., Prins, M.H., Bagatella, P., Scudeller, A. & Girolami, A. (1999) Which is the outcome of post-thrombotic syndrome? Thrombosis and Haemostasis, 82, 1358.
  • Rai, R.S., Regan, L., Clifford, K., Pickering, W., Dave, M., Mackie, I., McNally, T. & Cohen, H. (1995a)Antiphospholipid antibodies and beta2-glycoprotein-1 in 500 women with recurrent miscarriage: results of a comprehensive screening approach. Human Reproduction, 10, 2001–2005.
  • Rai, R.S., Clifford, K., Cohen, H. & Regan, L. (1995b) High prospective fetal loss rate in untreated pregnancies of women with recurrent miscarriage and antiphospholipid antibodies. Human Reproduction, 10, 3301–3304.
  • Rai, R.S., Cohen, H., Dave, M. & Regan, L. (1997) Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies). British Medical Journal, 314, 253–257.
  • Rauch, J., Tannenbaum, M. & Janoff, A.S. (1989) Distinguishing plasma lupus anticoagulants from anti-factor antibodies using Hexagonal (II) phase phospholipids. Thrombosis and Haemostasis, 62, 892–896.
  • Rooney, A.M., McNally, T., Mackie, I.J. & Machin, S.J. (1994) The Taipan snake venom time: a new test for lupus anticoagulant. Journal of Clinical Pathology, 47, 497–501.
  • Roubey, R.A.S. (1996) Antigenic specificities of antiphospholipid autoantibodies: implications for clinical laboratory testing and diagnosis of the antiphospholipid syndrome. Lupus, 5, 425–430.
  • Roubey, R.A., Maldonado, M.A. & Byrd, S.N. (1996) Comparison of an enzyme-linked immunosorbent assay for antibodies to beta-2-glycoprotein I and a conventional anticardiolipin immunoassay. Arthritis and Rheumatism, 39, 1606–1607.
  • Sanson, B.-J., Lensing, A.W.A., Prins, M.H., Ginsberg, J.S., Bakagan, Z.S., Lavenne-Pardange, E., Brenner, B., Dulitzky, M., Nielsen, J.D., Boda, Z., Turi, S., MacGillavry, M.R., Hamulyak, K., Theunissen, I.M., Hunt, B.J. & Buller, H.R. (1999) Safety of low-molecular-weight heparin in pregnancy: a systematic review. Thrombosis and Haemostasis, 81, 668–672.
  • Schleider, M.A., Nachman, R.L., Jaffe, E.A. & Coleman, M. (1976) A clinical study of the lupus anticoagulant. Blood, 48, 499–509.
  • Schulman, S., Svenungsson, E. & Granqvist, S. (1998) Anticardiolipin antibodies predict early recurrence of thromboembolism and death among patients with venous thromboembolism following anticoagulant therapy. American Journal of Medicine, 104, 332–333.
  • Selva-Oícallaghan, A., Ordi-Ros, J., Monegal-Ferran, F., Martinez, N., Cortos-Hernandez, F. & Vilardell-Tarres, M. (1998) IgA anticardiolipin antibodies – relation with other antiphospholipid antibodies and clinical significance. Thrombosis and Haemostasis, 79, 282–285.
  • Silver, R.K., MacGregor, S.N., Shool, J.S., Hobart, J.M., Neerhof, M.G. & Ragin, A. (1993) Comparative trial of prednisone plus aspirin versus aspirin alone in the treatment of anticardiolipin antibody-positive obstetric patients. American Journal of Obstetrics and Gynecology, 169, 1411–1417.
  • The Haemostasis and Thrombosis Task Force (1998) BCSH guidelines on oral anticoagulation: 3rd edition. British Journal of Haematology, 101, 374–387.
  • Thiagarajan, P., Pengo, V. & Shapiro, S.S. (1986) The use of the dilute Russell's viper venom time for the diagnosis of lupus anticoagulants. Blood, 68, 869–874.
  • Triplett, D.A., Stocker, K.F., Unger, G.A. & Barna, L.K. (1993) The Taxtarin/Ecarin ratio. A confirmatory test for lupus anticoagulants. Thrombosis and Haemostasis, 70, 925–931.
  • Tsutsumi, A., Matsuura, E., Ichikawa, K., Fujisaku, A., Mukai, M., Kobayashi, S.L. & Koike, T. (1996) Antibodies to beta2-glycoprotein I and clinical manifestations in patients with systemic lupus erythematosus. Arthritis and Rheumatism, 39, 1466–1474.
  • Vaarala, O., Puurunen, M., Manttari, M., Mannimen, V., Aho, K. & Palosuo, T. (1996) Antibodies to prothrombin imply a risk of myocardial infarction in middle-aged men. Thrombosis and Haemostasis, 75, 456–459.
  • Wilson, W.A., Gharavi, A.E., Koike, T., Lockshin, M.D., Branch, D.W., Piette, J.C., Brey, R., Derksen, R., Harris, E.N., Hughes, G.R., Triplett D.A. & Khamashta, M.A. (1999) International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome. Arthritis and Rheumatism, 42, 1309–1311.